Drug intelligence / Profile preview

heptelidic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intratumoral Injection
01

Overview

Heptelidic acid, also known as avocettin or koningic acid, is a naturally occurring sesquiterpene lactone. It functions as a potent, specific, and irreversible inhibitor of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH), a key enzyme in the glycolytic pathway. Its inhibitory action involves the covalent modification of a critical cysteine residue within the active site of GAPDH, thereby disrupting glycolysis, depleting cellular ATP, and inducing cytotoxicity, particularly in cancer cells that exhibit a high dependence on glycolysis (the Warburg effect). Beyond its primary role in glycolysis inhibition, heptelidic acid has also been observed to modulate the p38 MAPK pathway, induce apoptosis, and act as a selective inhibitor of mammalian DNA polymerases β and λ, as well as terminal deoxynucleotidyl transferase in family X of DNA polymerases. It is derived from fungi such as T. koningii and Aspergillus oryzae. Preclinical studies have demonstrated its anti-tumor efficacy in various cancer models, including pancreatic cancer, melanoma, pediatric B-cell acute lymphoblastic leukemia, and rhabdoid tumor of the kidney.

Other names
avocettinkoningic acid
02

Targets

POLL (DNA polymerase lambda)DNTT (Terminal deoxynucleotidyl transferase)POLB (DNA polymerase beta)GAPDH (Glyceraldehyde-3-phosphate dehydrogenase)

Beyond the preview

Go deeper on heptelidic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on heptelidic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call